PD Dr. med. Katrin Parmar


PD Dr. med. Katrin Parmar is a clinician-scientist currently working as a leading neurology consultant at the Rehaklinik Rheinfelden. Moreover she is an associate scholar at the Department of Neurology, University Hospital Basel and PI of the Translational Imaging in Neurology (ThINk).

She obtained a MD at the RWTH Aachen, Germany in 2008, passed the Swiss Neurology board in 2013 and was appointed as lecturer at the University of Basel in 2016. From April 2005 to October 2020 she worked at the Department of Neurology, University Hospital of Basel and is still closely connected to the Multiple Sclerosis Center Basel. The focus of Dr. Parmar’s research is in structural brain imaging in multiple sclerosis, specifically the cerebellum and the spinal cord. Between 2013 and 2015 she completed a post-doctoral training at the Brain Imaging Center of the Montreal Neurological Institute (Canada). To pursue her research, Dr. Parmar has been awarded several research grants including support from the Swiss National Science Foundation, the Freie Akademische Gesellschaft Basel and the Baasch Medicus Foundation.

Katrin P.
   PD Dr. med. Katrin Parmar

    Principal Investigator
    University Hospital Basel
    Petersgraben 4
    4031 Basel
    Switzerland


Projects

 

I. Spinal cord atrophy in Multiple Sclerosis:

 

  • Spinal cord (SC) atrophy is evaluated as a potential marker of disease progression in MS. This project focuses on the development, application and evaluation of SC segmentation strategies (CORDIAL, MDGRU for GM-WM differentiation) in close collaboration with Prof. Cattin and co-workers. Single and multi-center data are analysed retrospectively regarding SC volume changes and its relation to disease severity and progression.
  • Prospective study on structural analysis of spinal cord grey and white matter changes in patients with multiple sclerosis (SNSF sponsored - SNF 320030_156860); patient recruitment is closed.
  • Application of SC segmentation strategies to other neurological diseases.

 

II. Cerebellar atrophy in Multiple Sclerosis:

 

  • Temporal evolution of focal cerebellar changes in Multiple Sclerosis: a 7 year longitudinal study.

Research Team